- Home
- CNTB vs SHLT Comparison
CNTB vs SHLT Comparison
Compare CNTB & SHLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- SHLT
- Stock Information
- Founded
- CNTB 2012
- SHLT 1987
- Country
- CNTB United States
- SHLT Israel
- Employees
- CNTB N/A
- SHLT N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- SHLT Business Services
- Sector
- CNTB Health Care
- SHLT Consumer Discretionary
- Exchange
- CNTB Nasdaq
- SHLT Nasdaq
- Market Cap
- CNTB 55.2M
- SHLT 39.3M
- IPO Year
- CNTB 2021
- SHLT N/A
- Fundamental
- Price
- CNTB $0.81
- SHLT $2.60
- Analyst Decision
- CNTB Strong Buy
- SHLT Strong Buy
- Analyst Count
- CNTB 1
- SHLT 1
- Target Price
- CNTB $8.00
- SHLT $11.00
- AVG Volume (30 Days)
- CNTB 18.3K
- SHLT 3.8K
- Earning Date
- CNTB 04-15-2025
- SHLT 04-16-2025
- Dividend Yield
- CNTB N/A
- SHLT N/A
- EPS Growth
- CNTB N/A
- SHLT N/A
- EPS
- CNTB N/A
- SHLT N/A
- Revenue
- CNTB $24,116,000.00
- SHLT $55,939,000.00
- Revenue This Year
- CNTB N/A
- SHLT N/A
- Revenue Next Year
- CNTB $62.09
- SHLT N/A
- P/E Ratio
- CNTB N/A
- SHLT N/A
- Revenue Growth
- CNTB N/A
- SHLT N/A
- 52 Week Low
- CNTB $0.77
- SHLT $2.03
- 52 Week High
- CNTB $2.66
- SHLT $7.96
- Technical
- Relative Strength Index (RSI)
- CNTB 39.94
- SHLT 54.63
- Support Level
- CNTB $0.79
- SHLT $2.05
- Resistance Level
- CNTB $0.91
- SHLT $2.60
- Average True Range (ATR)
- CNTB 0.08
- SHLT 0.17
- MACD
- CNTB -0.00
- SHLT 0.03
- Stochastic Oscillator
- CNTB 26.15
- SHLT 100.00
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.